March 2, 2016
Feb. 23 — A lawsuit filed Feb. 16 asserts the Washington State Health Care Authority is excluding Medicaid coverage for very expensive hepatitis C medications such as Harvoni for all but the sickest patients in violation of federal statute.
The lawsuit, filed on behalf of Medicaid enrollees, follows nearly identical suits also seeking class action status that were filed in January against Washington insurers Group Health Cooperative and BridgeSpan Health Co., a Regence BlueShield affiliate . Both insurers have since modified their coverage policies for direct-acting antiviral medications used to clear the hepatitis C virus with Regence essentially adopting the standard of care.
Read the rest of the story here.
